David A. Siegel Harrow Health, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 29,300 shares of HROW stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,300

Previous 57,800 49.31%

Holding current value

$1 Million

Previous $1.21 Million 9.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.85 - $46.47 $594,225 - $1.32 Million	-28,500 Reduced 49.31%	29,300 $1.32 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $658,000 - $1.42 Million	-65,800 Reduced 53.24%	57,800 $1.21 Million
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $279,000 - $396,900	-30,000 Reduced 19.53%	123,600 $1.64 Million
Q4 2023 Feb 14, 2024	SELL	$8.1 - $16.36 $427,680 - $863,808	-52,800 Reduced 25.58%	153,600 $1.72 Million
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $620,126 - $975,935	-44,200 Reduced 17.64%	206,400 $2.97 Million
Q2 2023 Aug 14, 2023	SELL	$17.37 - $28.08 $1.03 Million - $1.66 Million	-59,100 Reduced 19.08%	250,600 $4.77 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $2.32 Million - $3.59 Million	167,300 Added 117.49%	309,700 $6.55 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $465,684 - $669,534	45,300 Added 46.65%	142,400 $2.1 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $217,467 - $823,528	-33,100 Reduced 25.42%	97,100 $1.17 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $217,467 - $823,528	-33,100 Reduced 25.42%	97,100 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $101,775 - $136,998	17,700 Added 15.73%	130,200 $948,000
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $285,165 - $364,776	-42,122 Reduced 27.24%	112,500 $767,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $662,813 - $935,736	-77,978 Reduced 33.52%	154,622 $1.34 Million
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $385,149 - $584,060	-55,100 Reduced 19.15%	232,600 $2.11 Million
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $519,036 - $860,139	77,700 Added 37.0%	287,700 $2.67 Million
Q1 2021 May 17, 2021	BUY	$6.26 - $11.03 $517,702 - $912,181	82,700 Added 64.96%	210,000 $1.42 Million
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $132,804 - $193,347	27,900 Added 28.07%	127,300 $873,000
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $468,174 - $731,584	99,400 New	99,400 $556,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $926M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account